argenx SE
Below you will find information from the register publication of inside information. The information has been provided by the organisation.
Registration date
16 nov 2023 - 13:48
Statutory name
argenx SE
Title
argenx Announces European Commission Approval of Subcutaneous VYVGART® (efgartigimod alfa) for Generalized Myasthenia Gravis
Date last update: 25 April 2026